CTSA Program Posters

The Irving Institute for Clinical and Translational Research, home to Columbia University’s CTSA Program Hub, provides resources to investigators in the areas of precision medicine and translational research through two unique resources focused on providing funding, education, research services, and mentorship programs to support advancement of projects. The Translational Therapeutics (TRx)

A Blue Ribbon taskforce convened in 2005 concluded that in order to effectively advance medical care in a region, “a strong translational research enterprise needed to be developed which could take basic discoveries from the laboratories, translate them into drugs and therapeutic devices, manage animal testing and clinical trials, and get them in the hands of groups that can advance them to market

Optional functions at the Scripps Hub include drug repurposing (Calibr, a Division of Scripps Research) and genomics (Rady Children’s Institute for Genomic Medicine; RCIGM). Calibr’s drug repurposing library ReFRAME (Repurposing, Focused Rescue, and Accelerated Medchem) contains nearly all small molecules in any phase of clinical development (~12,000). RCIGM streamlines genomic sequencing for

A core aspiration of the CTSA program is to enable all Hubs to operate as a synergistic network, pooling data and knowledge, expanding the scope of observational and interventional trials, and dramatically reducing the time and cost for biomedical discovery and evaluation. The CD2H cores are building the informatics prerequisites necessary to realize this vision.

Since 2012, the Network Science Program at the University of Florida Clinical and Translational Science Institute has conducted research and implemented interventions on the collaboration networks of researchers at UF. The program currently aims to apply accumulated methods and experiences to other research institutions and to facilitate interventions on cross-institutional collaborative

As the coordinating center for the CTSA Program, CLIC’s vision is to build innovative and dynamic ecosystems to support the CTSA program as a connected and collaborative consortium. Whether it is reporting your Common Metrics data, engaging in collaborative activities, disseminating information regarding your hubs’ news or events, or interacting with the CLIC website, CLIC is the place to go to

The Utah CCTS Cellular Translational Research Core (CTRC) was officially launched in 2016 as a part of the Utah CCTS Precision Medicine program. The main CTRC priorities have been 1) to provide support and services for the investigators interested in stem cell research; 2) establish new services related to the generation of CRISPR/Cas9-edited human stem cell lines; and 3) educate the community on

The goal of this proposal is to establish the UMass Integrative Biomarker Center (InBioC) that will apply powerful new technologies (genomic, proteomic, metabolomic, imaging technologies, nanotechnologies) and integrative analytics to well-curated human samples in order to clarify biological pathways, provide insights into disease mechanisms, identify new therapeutic targets, and define novel

Context: The CCTSI mission is to accelerate and catalyze the translation of innovative science into improved health and patient care throughout Colorado. Located at the University of Colorado Anschutz Medical Campus (CU-AMC), the CCTSI works in partnership with CU-Boulder, Colorado State University, University of Colorado Health, Children’s Hospital Colorado, Denver Health, Kaiser Permanente

Pediatric medical technology advancement is about a decade behind adult technology advancement. This technology lag was reflected in a lack of pediatric-specific innovation within the University of Minnesota (UMN). To address this institutional and national deficit, we developed a novel program around pediatric technology innovation. The Pediatric Health Innovation Program (PHIP) at the UMN